Growth Metrics

Dolby Laboratories (DLB) Change in Accured Expenses (2016 - 2025)

Dolby Laboratories' Change in Accured Expenses history spans 17 years, with the latest figure at $43.6 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 807.06% year-over-year to $43.6 million; the TTM value through Dec 2025 reached $61.6 million, up 2647.3%, while the annual FY2025 figure was $22.9 million, 166.13% up from the prior year.
  • Change in Accured Expenses reached $43.6 million in Q4 2025 per DLB's latest filing, down from $71.8 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $71.8 million in Q3 2025 to a low of -$105.3 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is -$2.0 million, with a median of $5.3 million recorded in 2021.
  • The largest YoY upside for Change in Accured Expenses was 935.69% in 2023 against a maximum downside of 1469.91% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at -$34.0 million in 2021, then soared by 116.94% to $5.8 million in 2022, then crashed by 654.95% to -$32.0 million in 2023, then skyrocketed by 115.02% to $4.8 million in 2024, then surged by 807.06% to $43.6 million in 2025.
  • Per Business Quant, the three most recent readings for DLB's Change in Accured Expenses are $43.6 million (Q4 2025), $71.8 million (Q3 2025), and -$76.2 million (Q2 2025).